Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1887
https://www.valueinhealthjournal.com/article/S1098-3015(13)03792-3/fulltext
Title :
Cost-Effectiveness of Mirabegron Compared with Antimuscarinics for the Treatment of Patients with Overactive Bladder in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03792-3&doi=10.1016/j.jval.2013.08.1887
First page :
A633
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1720